Related Experiment Video
Updated: Jul 27, 2026

11:17
Sensing of Barrier Tissue Disruption with an Organic Electrochemical Transistor
Published on: February 10, 2014
11.7K
Electrolyte-gated amorphous IGZO transistors with extended gates for prostate-specific antigen detection
Xuemei Yin1, Xingqi Ji1, Wenlong Liu1
1School of Integrated Circuits, Shandong University, Jinan 250100, China. yanzhuocheng@sdu.edu.cn.
Lab on a Chip
|June 7, 2024
Summary
This study introduces a novel portable biosensor for rapid prostate-specific antigen (PSA) detection using electrolyte-gated transistors. The device offers instant, sensitive prostate cancer screening at the point-of-care, improving diagnostic capabilities.
Area of Science:
- Materials Science
- Biomedical Engineering
- Electronics
Background:
- Prostate-specific antigen (PSA) testing is crucial for prostate cancer diagnosis and screening.
- Existing PSA detection methods are limited by cost, time, and stability.
- There is a need for rapid, portable, and stable PSA detection systems.
Purpose of the Study:
- To develop a portable biosensor for real-time, instant PSA detection.
- To utilize electrolyte-gated amorphous indium gallium zinc oxide (a-IGZO) transistors for enhanced sensitivity and stability.
- To establish a point-of-care system for prostate cancer screening.
Main Methods:
- Fabrication of a portable biosensor using a-IGZO transistors with an extended gate.
- Employment of liquid-free ionic conductive elastomer (ICE) as the gate dielectric.
- Integration of a separate, biodegradable sensing pad for stable biomolecular interaction.
Main Results:
- Achieved real-time PSA detection at low operating voltage (<2 V).
- Demonstrated a small subthreshold swing (<0.5 V dec-1) and high on-state current (∼4 × 10-4 A).
- Exhibited a linear response to PSA concentrations (1 fg mL-1 to 10 pg mL-1) with a low detection limit (400 ag mL-1) and rapid detection time (∼5.1 s).
- Maintained superior electronic performance for over six months.
Conclusions:
- The developed biosensor enables instant, sensitive, and stable PSA detection.
- Electrolyte-gated transistors show significant potential for point-of-care diagnostics.
- This technology can advance clinical screening, healthcare diagnostics, and biological management.

